Target intelligence / Profile preview

Peroxisomal and mitochondrial β-oxidation pathway (None)

Target
None
Molecular classification
Enzyme pathway, Fatty acid metabolic pathway, Not a receptor, transporter, or single molecule
01

Overview

The peroxisomal and mitochondrial β-oxidation pathway is a fundamental metabolic route in eukaryotic cells responsible for degrading fatty acids via successive removal of two-carbon acetyl-CoA units. In mitochondria, medium- and long-chain fatty acids undergo β-oxidation coupled with ATP synthesis, while peroxisomes preferentially oxidize very long-chain and branched fatty acids, generating hydrogen peroxide instead of ATP. The pathway involves a series of distinct but parallel enzymatic steps in each organelle, including activation of fatty acids, transport into the organelle, and sequential oxidation via dehydrogenases, oxidases, and thiolases. Disorders of these processes lead to energy deficiency, lipid accumulation, and toxic metabolite buildup, underlying many inherited and acquired metabolic diseases. Pharmacological manipulation of these pathways is used to treat certain lipid disorders and to probe metabolic flux in research settings[1][2][3][4].

Other names
β-oxidation pathwayFatty acid β-oxidationPeroxisomal β-oxidationMitochondrial β-oxidation
02

Mechanism of action

Induction of fatty acid oxidation enzymes via receptor activation (e.g., clofibrate acting via PPARα) Inhibition of fatty acid transport into mitochondria (etomoxir inhibits CPT1) Scavenging of reactive oxygen species (antioxidants like NACA restore redox balance) Modulation of peroxisomal ROS and downstream lipolysis

03

Biological functions

Fatty acid catabolismLipid metabolismEnergy production (acetyl-CoA for ATP synthesis in mitochondria)Regulation of lipid homeostasisReactive oxygen species metabolism (especially in peroxisomes)Synthesis and degradation of cellular lipids (e.g., synthesis of plasmalogens, myelin lipids)
04

Disease associations

Metabolic disorders (e.g., Zellweger spectrum disorders, adrenoleukodystrophy)Non-alcoholic fatty liver diseaseLipotoxicity (excessive fatty acid accumulation)Hepatic steatosisNeurological diseases (via myelin and lipid metabolism defects)Other conditions (microvesicular steatohepatitis, glial degeneration)
05

Safety considerations

Oxidative stress: Peroxisomal β-oxidation produces hydrogen peroxide, potentially causing tissue damage if catalase is impairedLipotoxicity: Uncontrolled fatty acid release and oxidation may promote cellular damage and metabolic diseaseNeurological risks: Defective peroxisomal β-oxidation may lead to myelin abnormalities and neurological symptomsHepatotoxicity: Induction or inhibition of β-oxidation pathways can lead to liver inflammation and steatosis
06

Interacting drugs

Clofibrate

3 more in the full profile.

07

Biomarkers

Plasma very long-chain fatty acids (VLCFA)Acyl-CoA oxidase 1 (ACOX1) mutations or activityHydrogen peroxide levels (H₂O₂)Catalase activityPEX2 protein levels

Beyond the preview

Go deeper on Peroxisomal and mitochondrial β-oxidation pathway (None).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Peroxisomal and mitochondrial β-oxidation pathway (None).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call